Search

everythinglearnresearchcommunity

for

Search:↓

Created microspheres show potential for safe and effective use in prostate artery embolization.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Dimeric peptide derivatives could help hair growth and treat hair loss safely.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

The Ysc84/SH3yl1 protein family is important for cell movement and the process of taking in materials by interacting with actin and cell membranes.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

PAR-1 may play a role in hair growth regulation in human hair follicles.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

OsPHR2 gene in rice enhances root growth and phosphorus accumulation.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

PGD2 stops hair growth and is higher in bald men with AGA.

NM2 and RLC phosphorylation are essential for normal inner ear hair cell function.

Activated ras can protect kidney cells from a certain substance that causes cell death.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Keratin mutations cause skin diseases and could lead to new treatments.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

PADs are crucial for healthy skin and hair, and their imbalance can cause skin and hair disorders.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

PN hydrates skin; PDRN heals and regenerates skin and hair.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.